On July 21, the Food and Drug Administration (TFDA) of the Ministry of Health and Welfare, Republic of China, announced that Winston Medical Supply Co., Ltd. initiated a voluntary recall of “Tetracycline Ophthalmic Ointment “Winston"" after its internal testing revealed that the active ingredient content did not conform to the original approved specifications.
Basic Information of Recalled Medication
- Product Name: Tetracycline Ophthalmic Ointment “Winston” (溫士頓鹽酸四環素眼藥膏)
- Indications: Bacterial infectious inflammation of the eyes.
- Active Ingredient: TETRACYCLINE HCL (EQ TO TETRACYCLINE HYDROCHLORIDE)
- License Number: DOH-MD-No. 052555
- Batch Number: TET-16029
- License Holder: Winston Medical Supply Co., Ltd.
Recall Details
- Recall Classification: Class II
- Official Dispatch No.: FDA-Yao-Zi No. 1061407100 (TFDA Medicinal Products Division)
- Dispatch Date: July 21, 2017
- Announcement Date: July 27, 2017
- Reason for Recall: Following a defective drug report, the manufacturer’s internal testing revealed that the active ingredient content did not conform to original approved specifications, prompting an evaluated voluntary recall.
Support Independent Perspectives & In-Depth Insights
Every thoughtful analysis and candid critique comes from our dedication to truth and quality. We choose not to follow sensational algorithms or clickbait headlines.
Sustaining independent research requires reader support. Make a one-time or monthly contribution, securely processed by Google.
Payments secured by Google · Manage or cancel anytime in your Google Account

Comments